Adrenocortical insufficiency
MONDO:0000004An endocrine or hormonal disorder that occurs when the adrenal cortex does not produce enough of the hormone cortisol and in some cases, the hormone aldosterone. It may be due to a disorder of the adrenal cortex (Addison's disease or primary adrenal insufficiency) or to inadequate secretion of ACTH by the pituitary gland (secondary adrenal insufficiency).
Also known as: adrenal cortical hypofunction, adrenal cortical insufficiency, adrenal gland insufficiency, adrenal insufficiency, adrenocortical insufficiency, hypocortisolemia, hypocortisolism, hypoadrenalism
78 clinical trials for this condition and its sub-types, 33 tagged with Adrenocortical insufficiency itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Adrenocortical insufficiency
-
Primary adrenal insufficiency 5 trials · 48 incl. sub-types
2 sub-types
- Chronic primary adrenal insufficiency 6 trials · 47 incl. sub-types Sub-types →
- Acute adrenal insufficiency 0 trials Sub-types →
-
Secondary adrenal insufficiency 3 trials
Most studied deeper sub-types
-
Could a spoonful of yoghurt replace awkward tongue dosing for a lifesaving steroid?
Disease control CompletedResearchers are testing whether hydrocortisone granules (Infacort) mixed with yoghurt or soft food get into the bloodstream as well as dry granules placed on the back of the tongue. The study enrolls 19 healthy adult men whose natural cortisol is temporarily suppressed with dexam…
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Granule vs tablet: can a new hydrocortisone form match the standard?
Disease control CompletedResearchers are testing whether a granule form of hydrocortisone called Infacort is absorbed into the body as well as standard hydrocortisone tablets (Cortef). The study enrolls healthy adults aged 18 to 55 and gives each participant both forms in a random order, once while fasti…
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a modified hydrocortisone mimic the Body's natural cortisol rhythm?
Disease control CompletedResearchers are testing Chronocort, a modified-release form of hydrocortisone, against standard immediate-release hydrocortisone in 30 healthy male volunteers. The study measures how the drug moves through the body, including how fast it reaches peak levels and how long it stays …
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Two hydrocortisone pills go Head-to-Head in adrenal insufficiency trial
Disease control CompletedResearchers are comparing two modified-release hydrocortisone pills, Chronocort and Plenadren, in adults with primary adrenal insufficiency, a condition where the adrenal glands do not make enough cortisol. The study is a phase 2, double-blind, crossover trial: participants recei…
Phase 2 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a Timed-Release hydrocortisone pill match the Body's overnight hormone rhythm?
Disease control CompletedResearchers are testing several modified, timed-release versions of hydrocortisone, a hormone drug, in healthy male volunteers. The study has two parts: one compares how six different formulations move through the body after a single nighttime dose, and the other checks whether t…
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a Modified-Release hydrocortisone mimic the Body's natural rhythm?
Disease control CompletedResearchers are testing how the body absorbs Chronocort, a modified-release hydrocortisone, compared with Cortef, a standard immediate-release hydrocortisone tablet. The study enrolls healthy adult men whose natural cortisol production is temporarily suppressed with dexamethasone…
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New pill could tame rare hormone disorder
Disease control CompletedThis study tested a new oral drug called atumelnant in 38 adults with classic congenital adrenal hyperplasia, a genetic condition causing hormone imbalances. The drug works by blocking a hormone receptor to lower excess adrenal hormones. Researchers measured safety, side effects,…
Phase 2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hormone treatment shows promise for rare adrenal disorder
Disease control CompletedThis study looked at the long-term safety of a medication called Chronocort in 76 people aged 16 and older with congenital adrenal hyperplasia (CAH), a condition where the body can't make enough cortisol. Researchers monitored for signs of over- or under-treatment, adrenal crises…
Phase 3 • Sponsor: Immedica Pharma AB • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could cheap steroids help hearts in shock?
Disease control CompletedThis study tested whether giving low doses of two steroids (hydrocortisone and fludrocortisone) helps adults with cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. 380 participants received either the steroids or a placebo. The main goal was…
Phase 3 • Sponsor: CMC Ambroise Paré • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New stent graft aims to fix aneurysms without major surgery
Disease control CompletedThis study tested a special stent graft (E-liac) to treat bulges in the iliac artery (aneurysms) without open surgery. 71 patients received the device, sometimes combined with other aortic grafts. The main goal was to prevent aneurysm rupture and death. Researchers tracked succes…
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug shows promise for rare hormone disorder
Disease control CompletedThis phase 2 trial tested a new drug called SPR001 in 24 adults with classic congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. The study aimed to see if SPR001 is safe and can improve hormone control. Participants took multiple doses of t…
Phase 2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Study aims to uncover hidden hormone failure in ICU patients
Knowledge-focused CompletedThis study looks at how the adrenal glands work in people who are critically ill, such as those with sepsis. Adrenal insufficiency may affect up to 77% of ICU patients, but current tests are not reliable. Researchers will measure hormone levels in 225 participants, including heal…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Scientists probe link between stress hormone and 'Bliss Molecule' in rare disease
Knowledge-focused CompletedThis study looked at how the body's natural endocannabinoids (similar to cannabis compounds) interact with the stress hormone cortisol in people with Cushing's syndrome, a condition of high cortisol. Researchers measured blood levels of these compounds in 40 participants, includi…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Italian study checks how well newborn screening detects rare hormone disorder
Knowledge-focused CompletedThis completed study looked at newborn screening for congenital adrenal hyperplasia (CAH) in Italy. Researchers reviewed medical records of 29 infants diagnosed with classic CAH between 2006 and 2019 to see how accurate the screening was. The goal was to measure the screening's s…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Hidden danger: low blood sugar in kids with adrenal gland disorder
Knowledge-focused CompletedThis study looked at how often children with a rare adrenal gland problem (congenital adrenal insufficiency) experience dangerously low blood sugar. Even with standard treatment, these children may have low blood sugar without obvious symptoms. Researchers monitored 9 children ag…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Diabetes drug semaglutide put to the test: can it reveal secrets of the adrenal gland?
Knowledge-focused CompletedThis completed study gave 22 healthy men a single dose of semaglutide (Rybelsus) or a placebo pill to see how it affects cortisol and other stress hormones. The goal was not to treat any disease, but to learn more about how GLP-1 drugs interact with the body's stress system. Part…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Prenatal steroid for CAH: safe for the brain? new study investigates
Knowledge-focused CompletedThis study evaluates the long-term cognitive development of children who were exposed to dexamethasone (a steroid) while in the womb because they were at risk for congenital adrenal hyperplasia (CAH). The goal is to see if the drug causes any thinking or memory problems. Research…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Rare enzyme Disorder's blood pressure mystery probed
Knowledge-focused CompletedThis completed study investigated why patients with Cytochrome P450 Oxidoreductase (POR) deficiency, a rare genetic condition, often develop high blood pressure and blood vessel damage. Researchers compared 51 participants (patients and healthy controls) using 24-hour blood press…
Sponsor: Ozge Bayrak Demirel • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:41 UTC